adenosine diphosphate has been researched along with fk 409 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirasawa, Y; Kita, Y; Maeda, K; Nishio, M; Yoshida, K | 2 |
2 other study(ies) available for adenosine diphosphate and fk 409
| Article | Year |
|---|---|
Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.
Topics: Adenosine Diphosphate; Administration, Oral; Analysis of Variance; Animals; Blood Platelets; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Epoprostenol; Male; Nitro Compounds; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombosis | 1995 |
Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Aorta; Blood Pressure; Cyclic GMP; Drug Stability; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitro Compounds; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1994 |